Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin and Thymosin α1 in Acute Aortic Dissection Surgery
NCT06966687Enrolling by invitation
- Sponsor
- Nanjing Medical University
- Start
- Apr 2025
- Primary completion
- Dec 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised trial of thymosin alpha 1 in aortic dissection (2 arms), sponsored by Nanjing Medical University. Primary endpoint: Sequential Organ Failure Assessment at 7 days. Started Apr 2025; status: enrolling by invitation.
02
Drugs
thymosin alpha 1
03
Conditions
aortic dissection
Beyond the preview
Go deeper on NCT06966687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06966687.